Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
430 JPY | +2.38% | +2.63% | -38.75% |
03-19 | SanBio Eyes Approval for Brain Injury Treatment Drug SB623 By March | MT |
03-19 | Jefferies Adjusts SanBio’s Price Target to 270 Yen From 310 Yen, Keeps at Underperform | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.75% | 193M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- 4592 Stock
- News SanBio Company Limited
- Sanbio : to Seek Regulatory OK in Japan for Regenerative Cell Medicine SB623